Journal of the American College of Nutrition, Vol 11, Issue 1 68-73, Copyright © 1992 by American College of Nutrition

CLINICAL TRIAL

Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)

S. J. DeMaio, S. B. King 3rd, N. J. Lembo, G. S. Roubin, J. A. Hearn, H. N. Bhagavan and D. S. Sgoutas
Andreas Gruentzig Cardiovascular Center, Department of Internal Medicine (Cardiology), Atlanta, GA.

To test whether alpha-tocopherol prevents restenosis following percutaneous transluminal coronary angioplasty (PTCA), we enrolled patients in a double-blind, placebo-controlled trial. Patients were randomized after successful PTCA to receive vitamin E in the form of dl-alpha-tocopherol, 1200 IU/day, orally vs an inactive placebo for 4 months. Patients' blood was analyzed at baseline and at 4 months post-PTCA for differences in plasma lipids, lipoproteins, apolipoproteins, alpha-tocopherol, retinol, beta-carotene and lipoperoxide concentrations. One hundred patients completed the protocol. No significant difference was found in any parameter except alpha-tocopherol level between the vitamin E group and the placebo group, verifying compliance. Follow-up cardiac catheterization was obtained in 83% of the patients receiving placebo and in 86% of the patients receiving dl-alpha-tocopherol. Including thallium and exercise stress testing, objective information was obtained for practically all the patients receiving dl-alpha-tocopherol or placebo. Restenosis was defined as the presence of a lesion with greater than or equal to 50% stenosis in a previously dilated artery segment and results were analyzed with respect to pre- and post-PTCA artery diameter, vessel diameter at follow-up, and restenosis rate. Patients receiving dl-alpha-tocopherol had a 35.5% restenosis angiographically documented vs 47.5% restenosis in patients receiving the placebo. The overall incidence of restenosis defined by an abnormal angiogram or thallium test or exercise stress test was 34.6% in patients receiving dl-alpha-tocopherol and 50% in patients receiving the placebo. This difference (p = 0.06) did not reach significance because of an inadequate sample size.

This article has been cited by other articles:

				J. Bleys, E. R Miller III, R. Pastor-Barriuso, L. J Appel, and E. Guallar Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 880 - 887. [Abstract] [Full Text] [PDF]

				P. R. Trumbo The Level of Evidence for Permitting a Qualified Health Claim: FDA's Review of the Evidence for Selenium and Cancer and Vitamin E and Heart Disease J. Nutr., February 1, 2005; 135(2): 354 - 356. [Abstract] [Full Text] [PDF]

				C. D. Morris and S. Carson Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, July 1, 2003; 139(1): 56 - 70. [Abstract] [Full Text] [PDF]

				N. Kaul, S. Devaraj, and I. Jialal {{alpha}}-Tocopherol and Atherosclerosis Experimental Biology and Medicine, January 1, 2001; 226(1): 5 - 12. [Abstract] [Full Text]

				P. W. Serruys, D. P. Foley, B. Hofling, J. Puel, H. D. Glogar, R. Seabra-Gomes, J. Goicolea, P. Coste, W. Rutsch, H. Katus, et al. Carvedilol for Prevention of Restenosis After Directional Coronary Atherectomy : Final Results of the European Carvedilol Atherectomy Restenosis (EUROCARE) Trial Circulation, April 4, 2000; 101(13): 1512 - 1518. [Abstract] [Full Text] [PDF]

				D. L. Tribble Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and ß-Carotene : A Statement for Healthcare Professionals From the American Heart Association Circulation, February 2, 1999; 99(4): 591 - 595. [Full Text] [PDF]

				G. L. Nunes, K. Robinson, A. Kalynych, S. B. King III, D. S. Sgoutas, and B. C. Berk Vitamins C and E Inhibit O2- Production in the Pig Coronary Artery Circulation, November 18, 1997; 96(10): 3593 - 3601. [Abstract] [Full Text]

				J.-C. Tardif, G. Cote, J. Lesperance, M. Bourassa, J. Lambert, S. Doucet, L. Bilodeau, S. Nattel, P. de Guise, and The Multivitamins and Probucol Study Group Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty N. Engl. J. Med., August 7, 1997; 337(6): 365 - 372. [Abstract] [Full Text] [PDF]

				G. L. Nunes, D. S. Sgoutas, R. A. Redden, S. R. Sigman, M. B. Gravanis, S. B. King III, and B. C. Berk Combination of Vitamins C and E Alters the Response to Coronary Balloon Injury in the Pig Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 156 - 165. [Abstract] [Full Text]

				M. J. Stampfer, C. H. Hennekens, J. E. Manson, G. A. Colditz, B. Rosner, and W. C. Willett Vitamin E Consumption and the Risk of Coronary Disease in Women N. Engl. J. Med., May 20, 1993; 328(20): 1444 - 1449. [Abstract] [Full Text]

				E. B. Rimm, M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett Vitamin E Consumption and the Risk of Coronary Heart Disease in Men N. Engl. J. Med., May 20, 1993; 328(20): 1450 - 1456. [Abstract] [Full Text]